Correlation Between Mineralys Therapeutics, and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Senti Biosciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Senti Biosciences.
Diversification Opportunities for Mineralys Therapeutics, and Senti Biosciences
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Senti is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Senti Biosciences go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Senti Biosciences
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Senti Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 4.46 times less risky than Senti Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Senti Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,673 in Senti Biosciences on November 2, 2024 and sell it today you would lose (1,231) from holding Senti Biosciences or give up 73.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Senti Biosciences
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Senti Biosciences |
Mineralys Therapeutics, and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Senti Biosciences
The main advantage of trading using opposite Mineralys Therapeutics, and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Mineralys Therapeutics, vs. SEI Investments | Mineralys Therapeutics, vs. Carlyle Group | Mineralys Therapeutics, vs. Centessa Pharmaceuticals PLC | Mineralys Therapeutics, vs. Alto Neuroscience, |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |